Adjustable gastric band

ReShape Lifesciences® Receives FDA PMA Supplement Approval for its Next-Generation Lap-Band® 2.0 FLEX

Retrieved on: 
Tuesday, December 12, 2023

IRVINE, Calif., Dec. 12, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the U.S. Food and Drug Administration (FDA) has granted approval of a PMA supplement for the company’s next generation, enhanced Lap-Band® 2.0 FLEX.

Key Points: 
  • IRVINE, Calif., Dec. 12, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences ® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the U.S. Food and Drug Administration (FDA) has granted approval of a PMA supplement for the company’s next generation, enhanced Lap-Band® 2.0 FLEX.
  • “PMA supplement approval for our next generation Lap-Band® 2.0 FLEX is a historic event for ReShape that is expected to be a key growth catalyst for the company’s Lap-Band® franchise,” stated Paul F. Hickey, President and Chief Executive Officer of ReShape Lifesciences.
  • “The enhanced Lap-Band® 2.0 FLEX development effort was physician-led with the goal of improving the patient experience.
  • “Lap-Band 2.0® FLEX will potentially remedy this issue because of the ability for self-correction, utilizing an internal reservoir system.

Los Angeles Weight Loss Surgeon, Dr. David Davtyan, Thrilled for New FDA Approved ReShape Lifesciences® Next-Generation Lap-Band® 2.0 FLEX

Retrieved on: 
Tuesday, December 26, 2023

BEVERLY HILLS, Calif., Dec. 26, 2023 /PRNewswire-PRWeb/ -- Dr. David Davtyan, a renowned surgeon and pioneer in weight loss surgery, is delighted to announce the FDA approval of ReShape Lifesciences' groundbreaking Lap-Band® 2.0 FLEX. Dr. Davytan was one of the first surgeons in the United States to offer the Lap-Band procedure and leads The Weight Loss Surgery Center of Los Angeles, a prestigious medical weight loss clinic in Beverly Hills. Dr. Davytan has dedicated his career to helping patients battle obesity through various surgical procedures. The enhanced Lap-Band® 2.0 FLEX development effort was physician-led, including input from Dr. Davtyan, with the goal of improving the patient experience. Compared to the current Lap-Band, the Lap-Band® 2.0 has a new feature called FLEX Technology, which acts as a relief valve, allowing larger pieces of food to more easily pass through the narrowed passage created by the band. This minimizes discomfort caused by the passage of large food pieces through the stoma. The Lap-Band® system has long been considered the safest and most durable weight loss option for obese patients. It is particularly ideal for those who are opposed to medically managed weight loss and prefer an anatomy-preserving surgery. Using this latest advancement, The Weight Loss Surgery Center of Los Angeles looks forward to continuing their mission of transforming lives through cutting-edge, safe and effective weight loss procedures.

Key Points: 
  • Dr. David Davtyan and his team at The Weight Loss Surgery Center of Los Angeles are looking forward to offering this innovative solution to their patients.
  • BEVERLY HILLS, Calif., Dec. 26, 2023 /PRNewswire-PRWeb/ -- Dr. David Davtyan , a renowned surgeon and pioneer in weight loss surgery , is delighted to announce the FDA approval of ReShape Lifesciences' groundbreaking Lap-Band® 2.0 FLEX.
  • Dr. Davytan was one of the first surgeons in the United States to offer the Lap-Band procedure and leads The Weight Loss Surgery Center of Los Angeles, a prestigious medical weight loss clinic in Beverly Hills.
  • Kia, The Weight Loss Surgery Center of Los Angeles, 877-923-7546, [email protected] , https://weightlosssurgeryla.com/
    View original content to download multimedia: https://www.prweb.com/releases/los-angeles-weight-loss-surgeon-dr-david-...

ReShape Lifesciences® Reports Third Quarter Ended September 30, 2023 Financial Results and 2024 Cost Reduction Plan

Retrieved on: 
Wednesday, November 8, 2023

IRVINE, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today reported financial results for the third quarter ended September 30, 2023 and provided a corporate strategic update.

Key Points: 
  • Combined with the cost reductions mentioned above, this will extend the company’s cash runway in 2024.
  • 11,737,899) and provided a Notice of Allowance for two additional patents (patent applications 16/993,110 and 17/581,792), providing foundational protection.
  • In point of fact, with these 2024 reductions, the company’s core operating expense reductions between 2022 and 2024 are estimated at $22 million, or 70%.
  • The company expects that these efforts will come to fruition during the fourth quarter of 2023 and the beginning of 2024.

ReShape Lifesciences® Submits FDA PMA Supplement Application for the Next-Generation Lap-Band® 2.0

Retrieved on: 
Monday, June 26, 2023

IRVINE, Calif., June 26, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences ® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced the submission of a Premarket Approval (PMA) supplement application to the U.S. Food and Drug Administration (FDA) for the company’s next generation, enhanced Lap-Band® 2.0, utilizing a band reservoir technology.

Key Points: 
  • IRVINE, Calif., June 26, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences ® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced the submission of a Premarket Approval (PMA) supplement application to the U.S. Food and Drug Administration (FDA) for the company’s next generation, enhanced Lap-Band® 2.0, utilizing a band reservoir technology.
  • “The PMA supplement submission is a significant milestone and is consistent with our second growth pillar to develop and, ultimately, commercialize new products and therapies,” stated Paul F. Hickey, President and Chief Executive Officer of ReShape Lifesciences.
  • “This next generation, enhanced Lap-Band® 2.0 was developed with physician feedback to improve the patient experience.
  • If approved, we believe that based on discussions with physicians, that there will be broad adoption by existing Lap-Band® surgeons and surgeons that newly adopt the Lap-Band® 2.0.”

ReShape Lifesciences® Reports First Quarter Ended March 31, 2023 Financial Results and Provides Corporate Update

Retrieved on: 
Monday, May 15, 2023

SAN CLEMENTE, Calif., May 15, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today reported financial results for the first quarter ended March 31, 2023 and provided a corporate strategic update.

Key Points: 
  • SAN CLEMENTE, Calif., May 15, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today reported financial results for the first quarter ended March 31, 2023 and provided a corporate strategic update.
  • “In 2023, we have continued to leverage operational efficiencies, optimize our lead generation programs, and invest in our growth drivers.
  • During the three months ended March 31, 2023, the company placed more focus on domestic sales, resulting in lower international sales.
  • Gross Profit for both the three months ended March 31, 2023, and 2022, was $1.2 million.

Nihalani Group Announces Partnership with New York Bariatric Group

Retrieved on: 
Tuesday, May 9, 2023

ROSLYN HEIGHTS, N.Y., May 9, 2023 /PRNewswire/ -- Dr. Anish Nihalani, General and Weight Loss surgeon practice with a strong presence in central New Jersey, announces a new partnership with New York Bariatric Group (NYBG), the nation's leading private bariatric service provider.

Key Points: 
  • ROSLYN HEIGHTS, N.Y., May 9, 2023 /PRNewswire/ -- Dr. Anish Nihalani, General and Weight Loss surgeon practice with a strong presence in central New Jersey, announces a new partnership with New York Bariatric Group (NYBG), the nation's leading private bariatric service provider.
  • Nihalani Group founder, Dr. Anish Nihalani, will join the distinguished NYBG team of 28 bariatric surgeons.
  • "We appreciate the contributions of Dr. Nihalani and his team in safety and standards they have provided in bariatric care," says Dr. Shawn Garber, founder and CEO of New York Bariatric Group.
  • The collaboration between the Nihalani Group and New York Bariatric Group will greatly impact support services, providing even greater accessibility to these resources for our patients."

The Weight Loss Surgery Center of LA Founder Dr. David Davtyan Points to Recently Completed 40-Year Study on Weight Loss Surgery Confirming Benefits of Bariatric Surgery

Retrieved on: 
Monday, February 13, 2023

LOS ANGELES, Feb. 13, 2023 /PRNewswire-PRWeb/ -- According to the recent U.S News and World Report article, "40-Year Study Finds Weight-Loss Surgery Extending Life Spans," a brand-new study published in the January edition of the Obesity medical journal, shows that weight-loss surgery could set a person's health and longevity on a different path. In the research, patients were followed for up to 40 years after they had one of four types of weight loss surgery (bariatric surgery), sleeve gastrectomy, laparoscopic adjustable gastric banding (commonly known as Lap-Band), Roux-en-Y gastric bypass, and biliopancreatic diversion with duodenal switch (BPDS). Researchers found that these patients had significant reductions in death rates from all causes (16% lower) compared to obese patients who did not have surgery. For heart disease, it was 29% lower, cancer deaths dropped by 43%, and it was down a full 72% for diabetes. The report concluded that having surgery is beneficial overall in extending life, and patients should probably have it sooner rather than later to prevent other diseases. At the Weight Loss Surgery Center of Los Angeles, a prominent weight loss center located in Beverly Hills, Dr. David Davytan performs the surgical procedures listed in the study and more to help his patients win their battle against obesity. Dr. Davtyan and his team treat every patient individually and construct personalized treatment plans that fit their unique needs and goals. The center offers a wide spectrum of cutting-edge medical endoscopic, surgical, and minimally invasive weight loss procedures combined with exceptional compassion, empathy, and expertise to provide excellent outcomes for patients.

Key Points: 
  • Leading specialist, Dr. David G. Davtyan, is board certified in surgery and is one of the top weight loss surgeons in the Los Angeles area.
  • Dr. David G. Davtyan is a highly-respected weight loss surgeon with over 28 years of experience and has treated thousands of patients with exceptional results.
  • Dr. Davtyan and his team offer top-quality weight loss surgery (bariatric surgery) and weight loss treatment in Los Angeles, Orange County, and the Inland Empire.
  • Dr. David Davytan, Weight Loss Surgery Center of Los Angeles, 877-923-7546, [email protected]

The Weight Loss Surgery Center of Los Angeles, Known for Gastric Sleeve Surgery (Sleeve Gastrectomy) Expertise, Recognized as Top Patient Rated Bariatric Surgery Center

Retrieved on: 
Friday, January 13, 2023

LOS ANGELES, Jan. 13, 2023 /PRNewswire-PRWeb/ -- The Weight Loss Surgery Center of Los Angeles has been selected as a 2023 Top Patient Rated LA Bariatric Surgery Clinic. This recognition from Find Local Doctors is a result of the numerous five-star ratings and positive reviews this clinic has received from patients through reputable online sources. Find Local Doctors is a user-friendly online directory, that helps consumers connect with skilled physicians in their area. The Weight Loss Surgery Center of Los Angeles is a private medical weight loss clinic, located in Beverly Hills. Dr. David Davtyan and his team have helped countless patients successfully deal with obesity and lose weight. They treat every patient as an individual and construct personalized treatment plans that fit unique needs and goals. The Weight Loss Surgery Center of Los Angeles offers a wide spectrum of cutting-edge medical endoscopic, surgical and minimally invasive weight loss procedures with excellent outcomes. They perform gastric balloons, gastric sleeve, endoscopic gastric sleeve (accordion procedure), Lap-Band and gastric plication. The experts at this clinic assist patients in overcoming weight loss challenges once and for all, so they can reclaim control of their bodies and wellness.

Key Points: 
  • Patients have five different weight loss clinic locations to choose from so Dr. Davtyan is very accessible to all of Los Angeles
    LOS ANGELES, Jan. 13, 2023 /PRNewswire-PRWeb/ -- The Weight Loss Surgery Center of Los Angeles has been selected as a 2023 Top Patient Rated LA Bariatric Surgery Clinic .
  • The Weight Loss Surgery Center of Los Angeles is a private medical weight loss clinic, located in Beverly Hills.
  • The Weight Loss Surgery Center of Los Angeles offers a wide spectrum of cutting-edge medical endoscopic, surgical and minimally invasive weight loss procedures with excellent outcomes.
  • Kia Motamedi, The Weight Loss Surgery Center of Los Angeles, 877-923-7546, [email protected]

Maryland Bariatric Center at Mercy Earns National Bariatric Surgery Accreditation and Quality Improvement Program Designation

Retrieved on: 
Friday, January 6, 2023

BALTIMORE, Jan. 5, 2023 /PRNewswire-PRWeb/ -- The Maryland Bariatric Center at Mercy has achieved Comprehensive Center accreditation by the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP), a joint quality program of the American College of Surgeons and the American Society for Metabolic and Bariatric Surgery. The MBSAQIP standards ensure that metabolic and bariatric patients receive multidisciplinary medical care, which improves patient outcomes and long-term success.

Key Points: 
  • BALTIMORE, Jan. 5, 2023 /PRNewswire-PRWeb/ -- The Maryland Bariatric Center at Mercy has achieved Comprehensive Center accreditation by the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP), a joint quality program of the American College of Surgeons and the American Society for Metabolic and Bariatric Surgery.
  • The MBSAQIP designation recognizes the Center's commitment to providing high-quality care to patients, said Kuldeep Singh, M.D., FACS, MBA, FASMBS , a Baltimore magazine "Top Doctor" in Bariatric Surgery, and Director of The Maryland Bariatric Center at Mercy.
  • "The decision to undergo bariatric surgery is a significant one in a patient's journey to realize their goal of better health.
  • Surgical weight loss options include Gastric Bypass Surgery (Roux-en-Y Surgery), Gastric Sleeve Surgery (Sleeve Gastrectomy), and Revision Bariatric Surgery (Revise a Previous Bypass, Lap Band or Gastric Sleeve Surgery).

ReShape Lifesciences™ Announces Publication of Data on Proprietary Diabetes Bloc-Stim Neuromodulation™ (DBSN™) System in Peer Reviewed, Frontiers in NeuroScience

Retrieved on: 
Tuesday, October 25, 2022

SAN CLEMENTE, Calif., Oct. 25, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that data on the Company’s proprietary Diabetes Bloc-Stim Neuromodulation™ (DBSN™) system has been published in the Neural Technology Section of the peer reviewed journal Frontiers in NeuroScience.

Key Points: 
  • When this translates to humans and clinical use, it may greatly impact the standard of care for type 2 diabetes.
  • This study specifically tested the ability of the system to increase glycemic control in a rat model of type 2 diabetes and Alloxan treated swine.
  • Based on the data generated, the study concluded that our proprietary DBSN system may be an adjustable and localized approach for treating type 2 diabetes.
  • The DBSN system utilizes a proprietary, reversable and adjustable electrical blockade felt to be key to the future of personalized medicine.